Quipt Home Medical Corp. operated as a U.S.-based home medical equipment provider focused on end-to-end respiratory care, in-home monitoring and disease management services for the U.S. healthcare market. Company updates centered on respiratory solutions, resupply activity, chronic disease management offerings, operating and financial results, capital-structure disclosure, governance matters and shareholder voting.
Quipt's later news documented the completed plan of arrangement through which all outstanding common shares were acquired for cash by a purchaser funded by affiliates of Kingswood Capital Management and Forager Capital Management. The completed transaction changed the public-company status of the former Nasdaq and TSX-listed QIPT common shares.
Quipt Home Medical Corp. (TSXV:QIPT; OTCQX:PTQQD) announced its common shares will begin trading on the Nasdaq Capital Market under the ticker symbol 'QIPT' on May 27, 2021. This listing marks a significant achievement for the Company, reflecting its growth and evolution as a publicly traded entity. CEO Greg Crawford highlighted that the Nasdaq listing will enhance liquidity and expand the shareholder base. Quipt specializes in in-home monitoring and disease management services, focusing on respiratory care and chronic health conditions.